{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:42:29Z","timestamp":1787240549679,"version":"build-2736575974"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.1093\/ndt\/gfl228","type":"journal-article","created":{"date-parts":[[2006,5,15]],"date-time":"2006-05-15T20:42:29Z","timestamp":1147725749000},"page":"2485-2490","source":"Crossref","is-referenced-by-count":58,"title":["Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and\/or medical approaches"],"prefix":"10.1093","volume":"21","author":[{"given":"Gabriella","family":"Moroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beniamina","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ponticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,5,15]]},"reference":[{"key":"key\n\t\t\t\t20171011053337_BIB1","doi-asserted-by":"crossref","unstructured":"Gilkeson GS, Allen NB. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am1996; 22: 23\u201338","DOI":"10.1016\/S0889-857X(05)70260-X"},{"key":"key\n\t\t\t\t20171011053337_BIB2","unstructured":"Parum DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoprotein and ceroid in the chronic periaortitis. Arch Pathol Lab Med1990; 114: 383\u2013387"},{"key":"key\n\t\t\t\t20171011053337_BIB3","doi-asserted-by":"crossref","unstructured":"Vaglio A, Corradi D, Manetti L etal. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med2003; 114: 454\u2013462","DOI":"10.1016\/S0002-9343(03)00056-1"},{"key":"key\n\t\t\t\t20171011053337_BIB4","doi-asserted-by":"crossref","unstructured":"Moroni G, Del Papa N, Moronetti LM etal. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease. Kidney Int2005; 68: 562\u2013568","DOI":"10.1111\/j.1523-1755.2005.00434.x"},{"key":"key\n\t\t\t\t20171011053337_BIB5","doi-asserted-by":"crossref","unstructured":"Higgins PM, Bennett-Jones DN, Naish PF, Aber GM. Non-operative management of retroperitoneal fibrosis. Br J Surg1988; 75: 573\u2013577","DOI":"10.1002\/bjs.1800750625"},{"key":"key\n\t\t\t\t20171011053337_BIB6","doi-asserted-by":"crossref","unstructured":"Heidenreich A, Derakhshani P, Neubauer S, Krug B. Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urologe A2000; 39: 141\u2013148","DOI":"10.1007\/s001200050022"},{"key":"key\n\t\t\t\t20171011053337_BIB7","doi-asserted-by":"crossref","unstructured":"Harreby M, Bilde T, Helin P, Meyhoff HH, Vinterberg H, Nielsen VA. Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol1994; 28: 237\u2013242","DOI":"10.3109\/00365599409181272"},{"key":"key\n\t\t\t\t20171011053337_BIB8","unstructured":"van Bommel EF, van Spengler J, van der Hoven B, Kramer P. Retroperitoneal fibrosis: report of 12 cases and a review of the literature. Neth J Med1991; 39: 338\u2013345"},{"key":"key\n\t\t\t\t20171011053337_BIB9","doi-asserted-by":"crossref","unstructured":"Marcolongo R, Tavolini IM, Laveder F. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med2004; 116: 194\u2013197","DOI":"10.1016\/j.amjmed.2003.08.033"},{"key":"key\n\t\t\t\t20171011053337_BIB10","unstructured":"Moroni G, Dore R, Collini P. Idiopathic retroperitoneal fibrosis. J Nephrol2005; 18: 794\u2013808"},{"key":"key\n\t\t\t\t20171011053337_BIB11","unstructured":"Clark CP, Vanderpool D, Preskitt JT. The response of retroperitoneal fibrosis to tamoxifen. Surgery1991; 109: 502\u2013506"},{"key":"key\n\t\t\t\t20171011053337_BIB12","doi-asserted-by":"crossref","unstructured":"Loffeld RJ, van Weel TF. Tamoxifen for retroperitoneal fibrosis. Lancet1993; 341: 382","DOI":"10.1016\/0140-6736(93)90195-M"},{"key":"key\n\t\t\t\t20171011053337_BIB13","doi-asserted-by":"crossref","unstructured":"Vivas I, Nicolas AI, Velazquez P, Elduayen B, Fernandez-Villa, Martinez-Cuesta A. Retroperitoneal fibrosis: typical and atypical manifestations. Br J Radiol2000; 73: 214\u2013222","DOI":"10.1259\/bjr.73.866.10884739"},{"key":"key\n\t\t\t\t20171011053337_BIB14","doi-asserted-by":"crossref","unstructured":"Wagenknecht LV, Hardy JC. Value of various treatments for retroperitoneal fibrosis. Eur Urol1981; 7: 193\u2013200","DOI":"10.1159\/000473218"},{"key":"key\n\t\t\t\t20171011053337_BIB15","doi-asserted-by":"crossref","unstructured":"Baker LRI, Mallison WJW, Gregory MC. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol1988; 60: 497\u2013503","DOI":"10.1111\/j.1464-410X.1987.tb05028.x"},{"key":"key\n\t\t\t\t20171011053337_BIB16","doi-asserted-by":"crossref","unstructured":"Speziale F, Sbarigia E, Grossi R, Maraglino C, Fiorani P. Inflammatory aneurysm of the abdominal aorta involving the ureters: is combined treatment really necessary. J Urol2001; 165: 27\u201331","DOI":"10.1097\/00005392-200101000-00007"},{"key":"key\n\t\t\t\t20171011053337_BIB17","unstructured":"Tralce L, Antonelli A, Dotti P, Cunico SC. Epidemiology, clinical features and treatment of idiopathic retroperitoneal fibrosis: our experience. Arch Ital Urol Androl2004; 76: 135\u2013139"},{"key":"key\n\t\t\t\t20171011053337_BIB18","doi-asserted-by":"crossref","unstructured":"Kardar AH, Kattan S, Lindstedt E, Hanash K. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol2002; 168: 550\u2013555","DOI":"10.1016\/S0022-5347(05)64677-0"},{"key":"key\n\t\t\t\t20171011053337_BIB19","doi-asserted-by":"crossref","unstructured":"Cooksey G, Powell PH, Singh M, Yeates WK. Idiopathic retroperitoneal fibrosis a long-term review after surgical treatment. Br J Urol1982; 54: 628\u2013631","DOI":"10.1111\/j.1464-410X.1982.tb13611.x"},{"key":"key\n\t\t\t\t20171011053337_BIB20","doi-asserted-by":"crossref","unstructured":"Amis ES Jr. Retroperitoneal fibrosis. AJR1991; 157: 321\u2013329","DOI":"10.2214\/ajr.157.2.1853816"},{"key":"key\n\t\t\t\t20171011053337_BIB21","doi-asserted-by":"crossref","unstructured":"Tiptaft RC, Costello AJ, Paris AMI, Blandy JP. The long-term follow-up of idiopathic retroperitoneal fibrosis. Br J Urol1982; 54: 620\u2013624","DOI":"10.1111\/j.1464-410X.1982.tb13609.x"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/9\/2485\/7624627\/gfl228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T18:01:12Z","timestamp":1555610472000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/9\/2485\/1938991\/Longterm-outcome-of-idiopathic-retroperitoneal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,15]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2006,5,15]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl228","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,9]]},"published":{"date-parts":[[2006,5,15]]}}}